Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma

Aliment Pharmacol Ther. 2024 Jun;59(11):1462-1464. doi: 10.1111/apt.17985. Epub 2024 Apr 21.

Authors

Enrico N De Toni¹, Julia Mayerle¹, Bettina Oehrle¹, Max Seidensticker², Lorenza Rimassa^{3

4}, Alexander Philipp¹, Daniel Roessler¹, Najib Ben Khaled¹

Affiliations

¹ Department of Medicine 2, University Hospital, LMU Munich, Munich, Germany.
² Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
³ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.
⁴ Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.

PMID: 38643505
DOI: 10.1111/apt.17985

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Hepatocellular* / therapy
Disease Progression*
Humans
Immunotherapy* / methods
Liver Neoplasms* / therapy
Research Design
Treatment Outcome